AbbVie
ABBV
#27
Rank
S$616.26 B
Marketcap
S$348.74
Share price
0.39%
Change (1 day)
16.41%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of June 2026 : S$172.96 Billion

According to AbbVie's latest financial reports the company's total assets are S$172.96 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$171.99 B-6.38%
2024-12-31S$183.72 B3.26%
2023-12-31S$177.91 B-4.39%
2022-12-31S$186.08 B-6.06%
2021-12-31S$198.09 B-0.55%
2020-12-31S$199.18 B65.79%
2019-12-31S$120.14 B48.17%
2018-12-31S$81.08 B-14.36%
2017-12-31S$94.67 B-1.03%
2016-12-31S$95.66 B27.48%
2015-12-31S$75.04 B106.42%
2014-12-31S$36.35 B-1.73%
2013-12-31S$36.99 B12.01%
2012-12-31S$33.02 B30.65%
2011-12-31S$25.28 B-7.14%
2010-12-31S$27.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
S$257.47 B 48.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$182.14 B 5.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$122.43 B-29.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$41.07 B-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$63.19 B-63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$112.18 B-35.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$148.28 B-14.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$104.72 B-39.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$6.86 B-96.03%๐Ÿ‡บ๐Ÿ‡ธ USA